Article
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Jun 2026
Crowell Cameron, Mankuzhy Nikhil P, Bennett Julie, Bandopadhayay Pratiti, Sturm Dominik, Green Adam L, Gupta Tejpal, Chatterjee Abhishek, Epari Sridhar, Chinnaswamy Girish, Prasad Maya, Patel Sohil H, MacNeil Mary, Vanan Magimairajan Issai, Larouche Valérie, Renzi Samuele, Jones Jacquelyn, Perreault Sébastien, Mata-Mbemba Daddy, Sangatsuda Yuhei, Yoshimoto Koji, Lin Emily, Feddersen Charlotte, Cruz Ofelia, Pavon-Mengual Miriam, Vizzini Olivia, Zápotocký Michal, Popovacki Aimee, Klawinski Darren, Hansford Jordan R, Schlosser Mary-Pat, Omene Egiroh, Alexander Kimberley L, Satgunaseelan Laveniya, Williams Andrew, Yao Kristin, Ronsley Rebecca, Cheng Sylvia, Ludlow Louise, Eisenstat David, Khuong-Quang Dong-Anh, Tabouret Emeline, André Nicolas, Matheson Kara, Chan Aimee, Lim-Fat Mary Jane, Lapointe Sarah, Cayrol Romain, Coleman Christina, Juretic Nikoleta, McThenia Sheila, Khan Sara, Wright-Nadkarni Mariah, Salloum Ralph, Galvin Robert T, Sener Ugur, Hawkins Cynthia, Imber Brandon S, Karajannis Matthias A, Jones David T W, Ligon Keith L, Jabado Nada, Erker Craig
Abstract excerpt
PURPOSE: Knowledge of prognostic factors and long-term survival in patients with diffuse hemispheric glioma, H3 G34-mutant (DHG, H3 G34), remains limited in this tumor with a poor prognosis. EXPERIMENTAL DESIGN: This retrospective, multi-institutional study investigated prognostic variables for patients with DHG, H3 G34, and their association with progression-free survival (PFS) and overall survival (OS). Uni-...
Topics
Join the communities discussing this publication.